Screener
Krystal Biotech, Inc. KRYS Business Segments — Gross margin
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept krys:OperatingGrossMarginPercentage.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
FAQ
- What is Krystal Biotech, Inc.'s business segments — gross margin?
- Krystal Biotech, Inc. (KRYS) reported business segments — gross margin of 95% in Q1 2026.
- How has Krystal Biotech, Inc.'s business segments — gross margin changed year-over-year?
- Krystal Biotech, Inc.'s business segments — gross margin increased by 1.1% year-over-year, from 94% to 95%.
- What does business segments — gross margin mean?
- Gross margin represents the total revenue generated by the reportable segment minus the direct costs associated with producing its goods or services. It serves as a primary indicator of the segment's production efficiency and the profitability of its core product offerings before accounting for operating expenses.
Ask your AI about Krystal Biotech, Inc.'s business segments — gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude